• SENSEX 73,895.74
    315.20 (+0.43%)
  • BANKNIFTY 55,580.40
    141.90 (+0.26%)
  • ICICI Bank
    1,311.70 1,187.55(%)
  • NSE
    1,790.00 1,790.00(%)
  • SS Retail
    692.30 603.00(%)
  • PB Fintech.
    1,115.10 1,115.10(%)
  • The Bombay Burmah
    1,425.75 1,301.00(%)
  • Hero Motors
    141.85 141.85(%)
  • Whirlpool India
    959.60 1,438.30(%)
  • Cholaman.Inv.&Fn
    1,638.05 1,299.80(%)
  • Larsen & Toubro
    3,885.90 4,440.00(%)
  • Tour. Fin. Corp.
    135.55 51.20(%)
  • Kotak Mah. Bank
    399.35 345.40(%)
  • AU Small Finance
    1,021.20 1,144.65(%)
  • Infosys
    991.75 984.00(%)
  • Rainbow Child.
    1,351.50 1,008.75(%)
  • Kaveri Seed Co.
    844.00 1,139.90(%)
  • Cupid
    274.15 298.95(%)
  • Reliance Industries
    1,227.20 1,611.20(%)
  • HDFC Bank
    739.50 1,020.35(%)
  • Shanti Gold
    333.00 333.00(%)
  • Tata Consumer
    979.10 979.10(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Ganga Pharmaceuticals Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 7505.0
  • ISIN : INE615T01017
12.50 1 (4.17%)
  • As on 27 Sep 2026 (EOD)

  • Today’s Low

    12.00

  • Today’s High

    12.50

  • Open

    12.00

  • Perv Close

    12.00

  • 52W Low

    9.35

  • 52W High

    13.97

Key Indicators

  • P/E(TTM)

    73.53

  • Mar.Cap (₹Cr.)

    7.39

  • Div & Yield %

    0.00

  • Book Value(₹)

    14.06

  • Debt-Equity Ratio

    4.17

  • AGM Date

    08-Sep-2026

  • EPS

    0.17

  • P/E Ratio

    73.53

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    7.39

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    5.91

  • BV (₹)

    14.10

  • Sales( ₹ in Cr.)

    2.83

  • NP (in Cr.)

    0.10

  • NP Var(%)

    28.0

  • Div%

    0.0

  • CPS (₹)

    0.30

  • EPS (₹)

    0.20

  • Traded Value (₹ in Lakhs)

    7.39

  • 52 Week High

    13.97

  • 52 Week Low

    9.35

  • Price BSE

    13.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    7.39

  • P/C Ratio

    48.80

  • P/E Ratio

    75.70

  • Price Vs.BV

    0.20

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 2.83 2.64 2.74 2.59 2.49 2.37
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 2.83 2.64 2.74 2.59 2.49 2.37
Other Income 0.28 0.44 0.24 0.30 0.26 0.25
Stock Adjustments -0.11 -0.01 0.07 0.10 0.01 0.18
Total Income 3.00 3.07 3.05 2.99 2.76 2.80
EXPENDITURE :            
Raw Materials 1.19 1.21 1.32 1.34 1.28 1.42
Power and Fuel Cost 0.00 0.00 0.00 0.00 0.00 0.00
Employee Cost 0.25 0.18 0.18 0.18 0.04 0.03
Other Manufacturing Expenses 0.01 0.00 0.00 0.01 0.02 0.01
Selling and Administration Expenses 1.12 1.22 1.15 1.10 1.09 1.05
Miscellaneous Expenses 0.10 0.14 0.10 0.06 0.02 0.01
Employee Benefit Expenses 0.25 0.18 0.18 0.18 0.04 0.03
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 2.68 2.75 2.75 2.68 2.45 2.53
Operating Profit 0.32 0.32 0.29 0.30 0.30 0.28
Interest 0.13 0.18 0.18 0.19 0.19 0.19
Gross Profit 0.19 0.14 0.11 0.11 0.11 0.09
Depreciation 0.06 0.05 0.05 0.06 0.05 0.05
Profit Before Tax 0.13 0.09 0.06 0.05 0.06 0.04
Current Tax 0.03 0.01 0.02 0.02 0.01 0.02
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00
Reported Net Profit 0.10 0.08 0.05 0.04 0.04 0.02
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 0.00
Adjusted Net Profit 0.10 0.08 0.05 0.04 0.04 0.02
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.91 0.83 0.78 0.74 0.70 0.68
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 1.01 0.91 0.83 0.78 0.74 0.70
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 0.17 0.16 0.10 0.10 0.09 0.05
Earnings Per Share(Adj)-Unit Curr - 0.16 - - 0.09 -
Book Value 14.06 13.46 13.30 13.42 13.32 13.23
Book Value(Adj)-Unit Curr - 13.46 - - 13.32 -

Shareholding Pattern

  • Promoter Group

    50.91%

  • Public Share Holding

    49.09%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 3,009,550 50.91 3,009,550 8
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 3,009,550 50.91 3,009,550 8
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 774,000 13.09 774,000 3
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 8,000 0.14 8,000 1
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 32,000 0.54 32,000 3
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,520,000 25.71 1,520,000 20
Individuals holding nominal share capital up to Rs. 1 lakh 567,950 9.61 377,100 330
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 2,901,950 49.09 2,711,100 357
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 5,911,500 100.00 5,720,650 365

Company Background

Ganga Pharmaceuticals LtdPharmaceuticals - Indian - Formulations

  • Ganga Pharmaceuticals Ltd
  • BSE Code : 7505.0
  • ISIN : INE615T01017

  • Incorporation Year

    1989

  • Registered Office

    Gangatat Dhanvantri Marg
    Gopcharpada Virar (E), Palghar,
    Maharashtra-401305

  • Telephone

    91-250-6098333/444

  • FAX

  • Chairman

    SANJAY VYANKATESH KULKARNI

  • Managing Director

    BHARAT BRIJMOHAN SHARMA

  • Company Secretary

  • Auditor

    Banka & Banka

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Ganga Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Ganga Pharma. 12.50 3.11 2.83 73.53 2.90
Abbott India 26,935.80 7,217.19 6,929.05 35.45 43.78
Astrazeneca Phar 6,517.85 2,304.07 2,275.58 96.06 27.86
Glaxosmi. Pharma 2,816.85 3,932.76 3,790.20 45.00 58.17
Novartis India 1,961.40 393.10 354.33 49.53 15.94
Cipla 1,397.20 20,102.60 18,979.95 36.72 13.88
Bliss GVS Pharma 709.30 773.53 729.81 65.92 12.51
Amrutanjan Healt 506.15 520.13 502.55 27.11 24.16
Fermenta Biotec. 468.15 474.15 450.25 21.86 18.77
Guj. Themis Bio. 417.30 168.25 165.82 111.58 18.05
Ambalal Sarabhai 40.55 19.52 3.94 75.09 6.77